CytoTools subsidiary completes establishment of German production and starts own production of DPOCL in Europe for the first time - Production notified to the responsible regional council in accordance with the German Drug Law - DermaTools is allowed to produce DPOCL for the European market - In-house production is used directly to manufacture the  [ … ]

Efficacy of DPOCL in COVID-19 confirmed by the Institute of Medical Virology at Frankfurt University Hospital - Virus-killing effect of DPOCL on SARS-CoV-2 pathogens confirmed in test series - New therapeutic approach to protect against infection by repeated daily inhalation - Search for project partner for Fast Track approval and market launch sta [ … ]

CytoTools starts phase III study of DermaPro in Europe - Study start in Germany in October and in up to seven other countries in the coming months - High prospects of success after approval and market launch in India - Sale of treasury shares generates extraordinary profit of EUR 0.33 million and creates additional financial leeway Darmstadt, 29 O [ … ]

CytoTools positions itself for the admission of new investors by extending the agenda of the coming general meeting - Postponement of the Annual General Meeting for comprehensive preparation of strategic steps - Extension of the agenda by new authorized capital - New strategic and institutional investors support the company's current course Darmst [ … ]

CytoTools secures financing of the phase III study and appoints Chief Financial Officer - Full financing of the Phase III study secured after registration of the capital increase - Marc Herwick appointed Chief Financial Officer of CytoTools AG Darmstadt, 6 October 2020 - The Management Board of CytoTools AG (ISIN DE000A0KFRJ1), a biotechnology hol [ … ]

CytoTools examines the effectiveness of its patented active substance DPOCL in COVID-19 infections - Novel therapeutic approach for easy treatment of COVID-19 with DPOCL - Proven active ingredient is delivered directly to the lungs as an inhalable aerosol - Anti-viral effect of DPOCL demonstrated in first cellular test systems Darmstadt, 17 Septem [ … ]

CytoTools partner Centaur Pharmaceuticals starts marketing the active substance DPOCL in India - Scientific market launch program of DPOCL under the brand WOXheal(R) started - Distribution via nationwide clinics chains and affiliated pharmacies - Marketing start considered promising despite pandemic-related restrictions Darmstadt, 3 September 2020 [ … ]

CytoTools introduces new strategic investor and restructures capital market communication- Pharma-CDMO Klocke Group participates as new strategic investor - Milestone for financing of phase III of the approval process for DermaPro(R) - Professionalization of investor relations for an improved capital market positioning through the signing of Interi [ … ]